Phreesia Announces Workforce Restructuring to Cut Operating Costs

Claim 55% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks An announcement from Phreesia ( (PHR) ) is now available. On May 7, 2026, Phreesia, Inc. implemented a restructuring plan aimed at reducing operating expenses and aligning its cost structure with current business priorities, including the elimination of about 220 positions, roughly half of which are contractor roles. The company said it does not expect the related costs to be material and anticipates they will be incurred primarily during fiscal 2027. Phreesia expects the restructuring to generate meaningful annualized run-rate expense savings that were already incorporated into its Adjusted EBITDA outlook for fiscal 2027 issued on March 30, 2026. The company cautioned that these expectations depend on various assumptions, and actual costs and savings could differ materially, with the possibility of additional unforeseen expenses arising from the plan. The most recent analyst rating on (PHR) stock is a Buy with a $9.00 price target. To see the full list of analyst forecasts on Phreesia stock, see the PHR Stock Forecast page. Spark’s Take on PHR Stock According to Spark, TipRanks’ AI Analyst, PHR is a Neutral. The score is driven primarily by improving fundamentals—sharp margin expansion and a strong swing to positive operating/free cash flow—supported by earnings-call evidence of profitability progress. These positives are tempered by weaker technical trends (below key moving averages with negative MACD), very expensive valuation (P/E ~348 with no dividend yield), and reduced FY27 revenue guidance that raises uncertainty in a higher-margin segment. To see Spark’s full report on PHR stock, click here. More about Phreesia Phreesia, Inc. is a healthcare technology company that provides digital patient intake and engagement solutions to medical practices, health systems and life sciences organizations. The company focuses on streamlining patient registration, improving practice workflows and enabling data-driven engagement across the healthcare ecosystem. Average Trading Volume: 2,015,803 Technical Sentiment Signal: Sell Current Market Cap: $618M For a thorough assessment of PHR stock, go to TipRanks’ Stock Analysis page.